Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Susan Haigney

Articles

The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.

Contractors Balance Increased Demand During COVID-19

Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain. 

Manufacturing APIs and the Supply Chain

Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.


Being Vigilant in Supplier Oversight

Contract manufacturers are making strategic partnerships and expanding services in the last quarter of 2019.

Author | Susan Haigney

Articles